share_log

康泰生物(300601.SZ):终止实施2023年股票期权与限制性股票激励计划暨注销股票期权及作废限制性股票

Shenzhen Kangtai Biological Products (300601.SZ): Termination of the implementation of the 2023 Stock Options and Restricted Stock Incentive Plan, as well as the cancellation of Stock Options and invalidation of Restricted Stocks.

Gelonghui Finance ·  Dec 31, 2024 20:46

On December 31, Gelonghui reported that Shenzhen Kangtai Biological Products (300601.SZ) announced that due to significant changes in the current Industry environment, market Operation environment, and other internal and external factors since the introduction of the 2023 Stock Options and Restricted Stock Incentive Plan, continuing to implement this incentive plan would be difficult to achieve the expected motivation objectives and effects. In order to better protect the interests of the company, Shareholders, and employees, and in consideration of the company's actual situation and future development plans, after careful study, the company intends to terminate the implementation of this incentive plan, cancel the Stock Options, and nullify the Restricted Stocks. Additionally, the related documents such as the "Draft of the 2023 Stock Options and Restricted Stock Incentive Plan" and the "2023 Stock Options and Restricted Stock Incentive Plan Implementation Assessment Management Measures" will also be terminated.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment